Evidence map›Paper›PMID 42760984›Full record

ArticlebioRxiv : the preprint server for biology2026

Programmed Clonal Expansion Associated with V(D)J Recombination Drives an ATM-Dependent Vulnerability Underlying Preferential Lymphocyte Depletion and Myeloid Bias Following DNA Damage.

Katherine H Lee, Zhengping Shao, Yunyue Wang, Brian J Lee, Angelina Li, Faye Yan, Peter A Sims, Shan Zha

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Katherine H LeeInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY 10032.
Zhengping ShaoInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY 10032.
Yunyue WangInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY 10032.
Brian J LeeInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY 10032.
Angelina LiInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY 10032.
Faye YanInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY 10032.
Peter A SimsDepartment of Systems Biology, College of Physicians & Surgeons, Columbia University, New York City, NY 10032.
Shan ZhaInstitute for Cancer Genetics, Vagelos College of Physicians and Surgeons, Columbia University, New York City, NY 10032.ORCID 0000-0002-6568-1818

Funding

Tumor Biology and Microenvironment ProgramP30CA013696 · NCI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI JOSEPH G JURCIC · 1985 to 2026
$115.3M
The Role of CTIP in Lymphocyte Development and LymphomagenesisP01CA174653 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GAUTIER, JEAN · 2014 to 2024
$17.6M
Studying the evolution of drug resistance in prostate cancer at the single cell levelU54CA274506 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Peter Alan Sims · 2023 to 2026
$9.1M
The role of HPF1 in radiation and genotoxic cancer therapyR01CA293675 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Shan Zha · 2024 to 2026
$3.0M
The non-catalytic function of PARP2 in DNA repair and cancer therapyR01CA271595 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Shan Zha · 2022 to 2026
$2.9M
The role of DNA-PKcs in DNA repair, lymphocyte development, RNA metabolism and tumor suppressionR01CA275184 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Shan Zha · 2022 to 2026
$2.7M
Genome and Epigenome Integrity In CancerT32CA265828 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Alberto Ciccia, Chao Lu · 2022 to 2026
$1.8M
The catalytic and non-catalytic functions of PARP1 in cancer biologyR01CA226852 · NCI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHA, SHAN · 2018 to 2022
$1.8M
NCI NIH HHS P01 CA174653NCI NIH HHS P30 CA013696NCI NIH HHS R01 CA226852NCI NIH HHS R01 CA271595NCI NIH HHS R01 CA275184NCI NIH HHS R01 CA293675NCI NIH HHS T32 CA265828NCI NIH HHS U54 CA274506
6 · The paper itself

Abstract

Myeloid bias is a hallmark of aging and genotoxic stress, yet the mechanisms underlying the preferential suppression of lymphopoiesis and the resulting predominance of myeloid cells following DNA damage remain incompletely understood. Here, we systematically characterized the acute hematopoietic response to a clinically relevant 2 Gy dose of ionizing radiation in young adult mice. Forty-eight hours after irradiation, overall bone marrow cellularity was reduced by ~50-60%, with hematopoietic stem and progenitor cells (HSPCs) and myeloid populations declining proportionally. Strikingly, immature and naïve B cells in the bone marrow and developing T cells in the thymus exhibited profound hypersensitivity, declining by ~90%, thereby recapitulating the preferential vulnerability of lymphocytes to DNA damage. Single-cell RNA sequencing mapped this vulnerability to cells undergoing programmed clonal expansion associated with V(D)J recombination. Specifically, B and T lymphocytes immediately following productive V(D)J recombination at the immunoglobulin heavy-chain (IgH) and T-cell receptor β (TCRβ) loci were the most radiosensitive, resulting in the marked depletion of the immediately downstream small pre-B and CD4

Identifiers

PMID42760984
PMCPMC13585025

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.